×

ENTER REPORT NAME TO SEARCH

Global Nanotechnology for Healthcare Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID: GIR2201040012 | Category: Medical Care | Pages: 122 | Format: PDF | Published Date: July 11,2022


Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Nanotechnology for Healthcare
    1.2 Classification of Nanotechnology for Healthcare by Type
        1.2.1 Overview: Global Nanotechnology for Healthcare Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Nanotechnology for Healthcare Revenue Market Share by Type in 2021
        1.2.3 Nanomedicine
        1.2.4 Nano Medical Devices
        1.2.5 Nano Diagnosis
        1.2.6 Other
    1.3 Global Nanotechnology for Healthcare Market by Application
        1.3.1 Overview: Global Nanotechnology for Healthcare Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Anticancer
        1.3.3 CNS Product
        1.3.4 Anti-infective
        1.3.5 Other
    1.4 Global Nanotechnology for Healthcare Market Size & Forecast
    1.5 Global Nanotechnology for Healthcare Market Size and Forecast by Region
        1.5.1 Global Nanotechnology for Healthcare Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Nanotechnology for Healthcare Market Size by Region, (2017-2022)
        1.5.3 North America Nanotechnology for Healthcare Market Size and Prospect (2017-2028)
        1.5.4 Europe Nanotechnology for Healthcare Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Nanotechnology for Healthcare Market Size and Prospect (2017-2028)
        1.5.6 South America Nanotechnology for Healthcare Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Nanotechnology for Healthcare Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Nanotechnology for Healthcare Market Drivers
        1.6.2 Nanotechnology for Healthcare Market Restraints
        1.6.3 Nanotechnology for Healthcare Trends Analysis
2 Company Profiles
    2.1 Amgen
        2.1.1 Amgen Details
        2.1.2 Amgen Major Business
        2.1.3 Amgen Nanotechnology for Healthcare Product and Solutions
        2.1.4 Amgen Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Amgen Recent Developments and Future Plans
    2.2 Teva Pharmaceuticals
        2.2.1 Teva Pharmaceuticals Details
        2.2.2 Teva Pharmaceuticals Major Business
        2.2.3 Teva Pharmaceuticals Nanotechnology for Healthcare Product and Solutions
        2.2.4 Teva Pharmaceuticals Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Teva Pharmaceuticals Recent Developments and Future Plans
    2.3 Abbott
        2.3.1 Abbott Details
        2.3.2 Abbott Major Business
        2.3.3 Abbott Nanotechnology for Healthcare Product and Solutions
        2.3.4 Abbott Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Abbott Recent Developments and Future Plans
    2.4 UCB
        2.4.1 UCB Details
        2.4.2 UCB Major Business
        2.4.3 UCB Nanotechnology for Healthcare Product and Solutions
        2.4.4 UCB Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 UCB Recent Developments and Future Plans
    2.5 Roche
        2.5.1 Roche Details
        2.5.2 Roche Major Business
        2.5.3 Roche Nanotechnology for Healthcare Product and Solutions
        2.5.4 Roche Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Roche Recent Developments and Future Plans
    2.6 Celgene
        2.6.1 Celgene Details
        2.6.2 Celgene Major Business
        2.6.3 Celgene Nanotechnology for Healthcare Product and Solutions
        2.6.4 Celgene Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Celgene Recent Developments and Future Plans
    2.7 Sanofi
        2.7.1 Sanofi Details
        2.7.2 Sanofi Major Business
        2.7.3 Sanofi Nanotechnology for Healthcare Product and Solutions
        2.7.4 Sanofi Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Sanofi Recent Developments and Future Plans
    2.8 Merck & Co
        2.8.1 Merck & Co Details
        2.8.2 Merck & Co Major Business
        2.8.3 Merck & Co Nanotechnology for Healthcare Product and Solutions
        2.8.4 Merck & Co Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Merck & Co Recent Developments and Future Plans
    2.9 Biogen
        2.9.1 Biogen Details
        2.9.2 Biogen Major Business
        2.9.3 Biogen Nanotechnology for Healthcare Product and Solutions
        2.9.4 Biogen Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Biogen Recent Developments and Future Plans
    2.10 Stryker 
        2.10.1 Stryker Details
        2.10.2 Stryker Major Business
        2.10.3 Stryker Nanotechnology for Healthcare Product and Solutions
        2.10.4 Stryker Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Stryker Recent Developments and Future Plans
    2.11 Gilead Sciences
        2.11.1 Gilead Sciences Details
        2.11.2 Gilead Sciences Major Business
        2.11.3 Gilead Sciences Nanotechnology for Healthcare Product and Solutions
        2.11.4 Gilead Sciences Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Gilead Sciences Recent Developments and Future Plans
    2.12 Pfizer
        2.12.1 Pfizer Details
        2.12.2 Pfizer Major Business
        2.12.3 Pfizer Nanotechnology for Healthcare Product and Solutions
        2.12.4 Pfizer Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 Pfizer Recent Developments and Future Plans
    2.13 3M Company
        2.13.1 3M Company Details
        2.13.2 3M Company Major Business
        2.13.3 3M Company Nanotechnology for Healthcare Product and Solutions
        2.13.4 3M Company Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 3M Company Recent Developments and Future Plans
    2.14 Johnson & Johnson
        2.14.1 Johnson & Johnson Details
        2.14.2 Johnson & Johnson Major Business
        2.14.3 Johnson & Johnson Nanotechnology for Healthcare Product and Solutions
        2.14.4 Johnson & Johnson Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.14.5 Johnson & Johnson Recent Developments and Future Plans
    2.15 Smith & Nephew
        2.15.1 Smith & Nephew Details
        2.15.2 Smith & Nephew Major Business
        2.15.3 Smith & Nephew Nanotechnology for Healthcare Product and Solutions
        2.15.4 Smith & Nephew Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.15.5 Smith & Nephew Recent Developments and Future Plans
    2.16 Leadiant Biosciences
        2.16.1 Leadiant Biosciences Details
        2.16.2 Leadiant Biosciences Major Business
        2.16.3 Leadiant Biosciences Nanotechnology for Healthcare Product and Solutions
        2.16.4 Leadiant Biosciences Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.16.5 Leadiant Biosciences Recent Developments and Future Plans
    2.17 Kyowa Hakko Kirin
        2.17.1 Kyowa Hakko Kirin Details
        2.17.2 Kyowa Hakko Kirin Major Business
        2.17.3 Kyowa Hakko Kirin Nanotechnology for Healthcare Product and Solutions
        2.17.4 Kyowa Hakko Kirin Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.17.5 Kyowa Hakko Kirin Recent Developments and Future Plans
    2.18 Shire
        2.18.1 Shire Details
        2.18.2 Shire Major Business
        2.18.3 Shire Nanotechnology for Healthcare Product and Solutions
        2.18.4 Shire Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.18.5 Shire Recent Developments and Future Plans
    2.19 Ipsen
        2.19.1 Ipsen Details
        2.19.2 Ipsen Major Business
        2.19.3 Ipsen Nanotechnology for Healthcare Product and Solutions
        2.19.4 Ipsen Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.19.5 Ipsen Recent Developments and Future Plans
    2.20 Endo International
        2.20.1 Endo International Details
        2.20.2 Endo International Major Business
        2.20.3 Endo International Nanotechnology for Healthcare Product and Solutions
        2.20.4 Endo International Nanotechnology for Healthcare Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.20.5 Endo International Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Nanotechnology for Healthcare Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Nanotechnology for Healthcare Players Market Share in 2021
        3.2.2 Top 10 Nanotechnology for Healthcare Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Nanotechnology for Healthcare Players Head Office, Products and Services Provided
    3.4 Nanotechnology for Healthcare Mergers & Acquisitions
    3.5 Nanotechnology for Healthcare New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Nanotechnology for Healthcare Revenue and Market Share by Type (2017-2022)
    4.2 Global Nanotechnology for Healthcare Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Nanotechnology for Healthcare Revenue Market Share by Application (2017-2022)
    5.2 Global Nanotechnology for Healthcare Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America Nanotechnology for Healthcare Revenue by Type (2017-2028)
    6.2 North America Nanotechnology for Healthcare Revenue by Application (2017-2028)
    6.3 North America Nanotechnology for Healthcare Market Size by Country
        6.3.1 North America Nanotechnology for Healthcare Revenue by Country (2017-2028)
        6.3.2 United States Nanotechnology for Healthcare Market Size and Forecast (2017-2028)
        6.3.3 Canada Nanotechnology for Healthcare Market Size and Forecast (2017-2028)
        6.3.4 Mexico Nanotechnology for Healthcare Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe Nanotechnology for Healthcare Revenue by Type (2017-2028)
    7.2 Europe Nanotechnology for Healthcare Revenue by Application (2017-2028)
    7.3 Europe Nanotechnology for Healthcare Market Size by Country
        7.3.1 Europe Nanotechnology for Healthcare Revenue by Country (2017-2028)
        7.3.2 Germany Nanotechnology for Healthcare Market Size and Forecast (2017-2028)
        7.3.3 France Nanotechnology for Healthcare Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Nanotechnology for Healthcare Market Size and Forecast (2017-2028)
        7.3.5 Russia Nanotechnology for Healthcare Market Size and Forecast (2017-2028)
        7.3.6 Italy Nanotechnology for Healthcare Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Nanotechnology for Healthcare Revenue by Type (2017-2028)
    8.2 Asia-Pacific Nanotechnology for Healthcare Revenue by Application (2017-2028)
    8.3 Asia-Pacific Nanotechnology for Healthcare Market Size by Region
        8.3.1 Asia-Pacific Nanotechnology for Healthcare Revenue by Region (2017-2028)
        8.3.2 China Nanotechnology for Healthcare Market Size and Forecast (2017-2028)
        8.3.3 Japan Nanotechnology for Healthcare Market Size and Forecast (2017-2028)
        8.3.4 South Korea Nanotechnology for Healthcare Market Size and Forecast (2017-2028)
        8.3.5 India Nanotechnology for Healthcare Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Nanotechnology for Healthcare Market Size and Forecast (2017-2028)
        8.3.7 Australia Nanotechnology for Healthcare Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America Nanotechnology for Healthcare Revenue by Type (2017-2028)
    9.2 South America Nanotechnology for Healthcare Revenue by Application (2017-2028)
    9.3 South America Nanotechnology for Healthcare Market Size by Country
        9.3.1 South America Nanotechnology for Healthcare Revenue by Country (2017-2028)
        9.3.2 Brazil Nanotechnology for Healthcare Market Size and Forecast (2017-2028)
        9.3.3 Argentina Nanotechnology for Healthcare Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Nanotechnology for Healthcare Revenue by Type (2017-2028)
    10.2 Middle East & Africa Nanotechnology for Healthcare Revenue by Application (2017-2028)
    10.3 Middle East & Africa Nanotechnology for Healthcare Market Size by Country
        10.3.1 Middle East & Africa Nanotechnology for Healthcare Revenue by Country (2017-2028)
        10.3.2 Turkey Nanotechnology for Healthcare Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Nanotechnology for Healthcare Market Size and Forecast (2017-2028)
        10.3.4 UAE Nanotechnology for Healthcare Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer